Tue 1 Dec 2009 | 1:32 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Sucampo Pharmaceuticals, Inc.

Sucampo Pharmaceuticals, Inc. (SCMP.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Pharmaceuticals - Diversified ยท View SCMP on other exchanges
As of  30 Nov 2009
3.31USD
Price Change
-0.16
Percent Change
-4.61%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Dolecek, Gayle 66 2008 Senior Vice President - Research and Development, Director
Dodds, David -- 2009 President of Sucampo Pharma Europe, Ltd
Miele, Stanley 45 2009 President of Sucampo Pharma Americas, Inc
Kuno, Sachiko 54 2008 Director
Maudlin, Timothy 58 2006 Director
Celeste, Anthony 70 2007 Director
Ferrara, Andrew 69 2008 Director
Ashton, William -- 2009 Director
Egan, James 54 2009 Chief Operating Officer
Smilek, Jan 42 2008 Chief Financial Officer, Vice President - Finance, Corporate Controller
Ueno, Ryuji 55 2007 Chairman of the Board, Chief Executive Officer, Chief Scientific Officer